{
    "root": "350884ec-5351-1828-e063-6294a90a2c10",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Methimazole",
    "value": "20250513",
    "ingredients": [
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "METHIMAZOLE",
            "code": "554Z48XN5E",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50673"
        }
    ],
    "indications": {
        "text": "methimazole tablets indicated : patients graves \u2019 disease hyperthyroidism toxic multinodular goiter surgery radioactive iodine therapy appropriate treatment option . ameliorate symptoms hyperthyroidism preparation thyroidectomy radioactive iodine therapy .",
        "doid_entities": [
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "hyperthyroidism (DOID:7998)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_7998"
            },
            {
                "text": "multinodular goiter (DOID:0050489)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050489"
            },
            {
                "text": "goiter (DOID:12176)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12176"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "methimazole tablets administered orally . total daily usually given 3 divided doses approximately 8-hour intervals . adult - initial daily 15 mg mild hyperthyroidism , 30 40 mg moderately severe hyperthyroidism , 60 mg severe hyperthyroidism , divided 3 doses 8-hour intervals . maintenance 5 15 mg daily . pediatric - initially , daily 0.4 mg/kg body weight divided 3 doses given 8-hour intervals . maintenance approximately 1/2 initial dose .",
        "doid_entities": [
            {
                "text": "hyperthyroidism (DOID:7998)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_7998"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "methimazole tablets , usp 10 mg - white off-white , round tablets debossed `` 656 `` one side `` b/p `` side . ndc 71335-2218-1 : 30 tablets bottle ndc 71335-2218-2 : 15 tablets bottle ndc 71335-2218-3 : 90 tablets bottle store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] . dispense tight , light-resistant container . repackaged/relabeled : bryant ranch prepack , inc. burbank , ca 91504",
    "adverseReactions": "methimazole tablets contraindicated presence hypersensitivity product components .",
    "indications_original": "Methimazole tablets are\u00a0indicated:\n                  \n                     In patients with Graves\u2019 disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option.\n                     To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy.",
    "contraindications_original": "Methimazole tablets\u00a0are administered orally. The total daily dosage is usually given in 3 divided doses at approximately 8-hour intervals.\n                  \n                     \n                        Adult\n                     - The initial daily dosage is 15 mg for mild hyperthyroidism, 30 to 40 mg for moderately severe hyperthyroidism, and 60 mg for severe hyperthyroidism, divided into 3 doses at 8-hour intervals. The maintenance dosage is 5 to 15 mg daily.\n\n \n                  \n                  \n                     \n                        Pediatric\n                     - Initially, the daily dosage is 0.4 mg/kg of body weight divided into 3 doses and given at 8-hour intervals. The maintenance dosage is approximately 1/2 of the initial dose.",
    "warningsAndPrecautions_original": "Methimazole Tablets, USP 10 mg - White to off-white, round tablets debossed with \"656\" on one side and \"B/P\" on the other side.\n                  \n                     NDC 71335-2218-1: 30 Tablets in a BOTTLE\n                     NDC 71335-2218-2: 15 Tablets in a BOTTLE\n                     NDC 71335-2218-3: 90 Tablets in a BOTTLE\n                  \n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F); excursions permitted between 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [See USP Controlled Room Temperature].\n                  Dispense in tight, light-resistant container.\n                  \n                  Repackaged/Relabeled by:\n  \nBryant Ranch Prepack, Inc.\n  \nBurbank, CA 91504",
    "adverseReactions_original": "Methimazole tablets are contraindicated in the presence of hypersensitivity to the drug or any of the other product components.",
    "drug": [
        {
            "name": "Methimazole",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50673"
        }
    ]
}